A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2009
12/10/2009	WO2009149094A2 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide
12/10/2009	WO2009148954A2 Dosing regimen
12/10/2009	WO2009148896A2 Anti-phospho-akt antibodies
12/10/2009	WO2009148659A2 Antimalarial quinolines and methods of use thereof
12/10/2009	WO2009148654A2 Cephalotaxus esters, methods of synthesis, and uses thereof
12/10/2009	WO2009148623A2 Methods and related compositions for the treatment of cancer
12/10/2009	WO2009148620A2 Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
12/10/2009	WO2009148599A1 Pyrrole compunds that modulate hsp90 activity
12/10/2009	WO2009148593A1 Identification and use of prognostic and predictive markers in cancer treatment
12/10/2009	WO2009148554A1 Achievement of high therapeutic index through molecular imaging guided targeted drug treatment
12/10/2009	WO2009148488A2 Use of oncolytic herpes viruses for killing cancer stem cells
12/10/2009	WO2009148346A1 Water soluble binuclear cation nitrosyl complexes of iron with natural aliphatic thiolyl
12/10/2009	WO2009148192A1 Alpha helix mimetics and methods relating thereto
12/10/2009	WO2009148169A1 Tumor treatment technique using liposome encapsulating ammine-platinum complex at high concentration
12/10/2009	WO2009148148A1 Neuroinvasion inhibitor
12/10/2009	WO2009148121A1 Novel molecular assembly, molecular probe for molecular imaging and molecular probe for drug delivery system using the same, and molecular imaging system and drug delivery system
12/10/2009	WO2009147984A1 Dna encoding polypeptide involved in biosynthesis of herboxidiene
12/10/2009	WO2009147843A1 Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
12/10/2009	WO2009147781A1 Antitumor agent
12/10/2009	WO2009147742A1 Sirna of human osteopontin
12/10/2009	WO2009147695A1 Anticancer agent
12/10/2009	WO2009147439A1 Anti-tumoural effects of cannabinoid combinations
12/10/2009	WO2009147438A1 Cannabinoids in combination with non -cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents)
12/10/2009	WO2009147331A1 Use of a dead-box rna helicase for inducing cytokine production
12/10/2009	WO2009147238A1 Solid pharmaceutical formulations comprising bibw 2992
12/10/2009	WO2009147218A1 Pharmaceutical combination
12/10/2009	WO2009147217A1 Dihydro-iso-ca-4 and analogues: potent cytotoxics, inhibitors of tubulin polymerization
12/10/2009	WO2009147188A1 Benzpyrazol derivatives as inhibitors of pi3 kinases
12/10/2009	WO2009147187A1 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases
12/10/2009	WO2009147169A1 Pharmaceuticl compositions useful for the treatment of cancers, in particular acute myeloid leukemia and acute promyelocytic leukemia
12/10/2009	WO2009146910A1 4, 6-diphenylpyrid-2-0nes against cancer
12/10/2009	WO2009146871A1 5-lipoxygenase inhibitors
12/10/2009	WO2009146750A1 Anti-cancer immune-modulating agent
12/10/2009	WO2009146546A1 8-hydroxyquinoline derivatives for the treatment of hematological malignancies
12/10/2009	WO2009146523A1 Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
12/10/2009	WO2009124330A3 Treatment of tumors
12/10/2009	WO2009120712A3 Compositions and methods for diagnosing and treating melanoma
12/10/2009	WO2009112488A3 Polyether polyol dendron conjugates with effector molecules for biological targeting
12/10/2009	WO2009111428A3 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof
12/10/2009	WO2009110984A3 Contrast agents for applications including perfusion imaging
12/10/2009	WO2009108706A3 Methods for inhibiting six 1 and eya proteins
12/10/2009	WO2009106566A3 Therapy selection method
12/10/2009	WO2009098715A4 Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
12/10/2009	WO2009077857A3 Trail variants for treating cancer
12/10/2009	WO2009073524A3 Conjugates of anti-rg-1 antibodies
12/10/2009	WO2009059994A3 Methods and compositions for measuring wnt activation and for treating wnt-related cancers
12/10/2009	WO2009056634A3 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)
12/10/2009	WO2008109498A8 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof
12/10/2009	US20090306214 Use of Syk Tyrosine Kinase Inhibitors for the Treatment of Cell Proliferative Disorders
12/10/2009	US20090306207 Treatment of Drug-Resistant Proliferative Disorders
12/10/2009	US20090306201 Selective inhibitors for transferases
12/10/2009	US20090306198 Anti-Oxidant Synergy Formulation Nanoemulsions to Treat Caner
12/10/2009	US20090306191 Treatment of a disease or a condition associated with aberrant gene hypomethylation by a method involving tailored epigenomic modification
12/10/2009	US20090306187 Modulators of Itch Ubiquitinase Activity
12/10/2009	US20090306185 Nanogenomics for medicine: siRNA engineering
12/10/2009	US20090306155 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
12/10/2009	US20090306145 Pyridylisoxazole Derivatives
12/10/2009	US20090306132 Use of derivatives of naphthalenesulphonic or quinolinesulphonic acid in the treatment of vasoproliferative ocular diseases
12/10/2009	US20090306130 Novel tetrahydro-isoquinolines
12/10/2009	US20090306127 Certain Chemical Entities, Compositions and Methods
12/10/2009	US20090306122 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially of tyrosine and raf kinases
12/10/2009	US20090306118 Trisubstituted Thiophenes as Progesterone Receptor Modulators
12/10/2009	US20090306116 Pyrimidine derivatives for the inhibition of igf-ir tyrosine kinase activity
12/10/2009	US20090306107 Organic Compounds
12/10/2009	US20090306103 Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders
12/10/2009	US20090306101 Combination treatment of cancer comprising egfr/her2 inhibitors
12/10/2009	US20090306098 Combination of roscovitine and a hdca inhibitor to treat proliferative diseases
12/10/2009	US20090306094 Pharmacogenetics around BCR-ABL individuals with drug bosutinib; determining if they will have drug resistance
12/10/2009	US20090306087 Compounds and Methods for Kinase Modulation, and Indications Therefor
12/10/2009	US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009	US20090306070 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use
12/10/2009	US20090306069 Azolidinone-vinyl fused-benzene derivatives
12/10/2009	US20090306067 2, 4-diaminopyrimidide derivates and their use for the treatment of cancer
12/10/2009	US20090306058 Sulphone Derivatives for Treatment of Cancer
12/10/2009	US20090306056 Pyrrolo-pyridine kinase modulators
12/10/2009	US20090306049 Treatment of Barrett's Esophagus
12/10/2009	US20090306044 Quinazoline derivatives for the treatment of cancer diseases
12/10/2009	US20090306041 Inhibitors of Bruton's tyrosine kinase
12/10/2009	US20090306034 Use of picoplatin to treat colorectal cancer
12/10/2009	US20090306020 Combination therapy comprising diaryl ureas for treating diseases
12/10/2009	US20090306015 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds
12/10/2009	US20090306014 C-10 carbamates of taxanes
12/10/2009	US20090306012 Therapeutic protocols
12/10/2009	US20090306008 3'-ethynylcytidine derivative
12/10/2009	US20090306007 Nucleosides with antiviral and anticancer activity
12/10/2009	US20090306004 Grafted macromolecular conjugates of doxorubicin with anticancer activity and method of their preparation
12/10/2009	US20090306001 Novel amphiphilic derivatives of alpha-c-phenyl-n-tert-butylnitrone
12/10/2009	US20090305998 Hsp90 inhibitors
12/10/2009	US20090305994 Compounds Modulating Vegf Receptor and Uses Thereof
12/10/2009	US20090305991 33 Human Secreted Proteins
12/10/2009	US20090305982 Muteins of tear lipocalin and methods for obtaining the same
12/10/2009	US20090305979 Compositions comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
12/10/2009	US20090305963 Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis
12/10/2009	US20090305956 Treatment of Ras-Expressing Tumors
12/10/2009	US20090305955 Cyclopeptide with Anti-Cancer Activity Derived from Collagen Type IV
12/10/2009	US20090305951 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells
12/10/2009	US20090305418 Cell therapy method for the treatment of tumors
12/10/2009	US20090305411 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
12/10/2009	US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
12/10/2009	US20090305350 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides

1 ... 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 ... 2211